Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycemic variability and hypoglycemia in type 2 diabetes with advanced renal dysfunction
RBR-8pd5zrNot yet recruiting
- Sponsor
- Pontifícia Universidade Católica do Paraná
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of insulin isophane, insulin glargine and insulin degludec in type 2 diabetes mellitus (T2DM) (3 cohorts), sponsored by Pontifícia Universidade Católica do Paraná. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
insulin isophaneinsulin glargineinsulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on RBR-8pd5zr.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8pd5zr.